Viewing Study NCT00398957


Ignite Creation Date: 2025-12-24 @ 6:48 PM
Ignite Modification Date: 2026-01-18 @ 3:49 PM
Study NCT ID: NCT00398957
Status: COMPLETED
Last Update Posted: 2010-04-27
First Post: 2006-11-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open-Label Evaluation of the Dose Proportionality of OROS� Hydromorphone HCL Tablets 8mg, 16mg, 32mg, 64mg
Sponsor: Alza Corporation, DE, USA
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Analgesia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Analgesia View